human | Q5 |
P106 | occupation | researcher | Q1650915 |
Q123362432 | 2095. Associations between Invasive Aspergillosis and Cytomegalovirus Infections in Lung Transplant Recipients |
Q123139413 | 82. Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study |
Q95628605 | A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19 |
Q115590311 | A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19 |
Q97559098 | Accelerated treatment of endocarditis-The POET II trial: Rationale and design of a randomized controlled trial |
Q99237703 | Azole-Resistant Aspergillus fumigatus Among Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H |
Q50578022 | Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort study. |
Q37417520 | Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study |
Q38256219 | Cryptococcal rib osteomyelitis as primary and only symptom of idiopathic CD4 penia |
Q24794053 | Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study. |
Q35880756 | Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. |
Q114665625 | Disseminated fusariosis with cerebral involvement in a patient with acute myeloid leukemia: Successful outcome with intrathecal –and systemic antifungal treatment |
Q38680375 | Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study |
Q38934525 | ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients |
Q30248345 | ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients |
Q38934528 | ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients |
Q40190647 | Echocardiographic findings suggestive of infective endocarditis in asymptomatic Danish injection drug users attending urban injection facilities |
Q92343751 | Fatal chronic meningitis caused by Candida dubliniensis after liver transplantation |
Q38694560 | Immune reconstitution syndrome presenting as probable AIDS-related lymphoma: a case report |
Q33919017 | Influence of Factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study |
Q30983646 | Infrequent detection of Pneumocystis jirovecii by PCR in oral wash specimens from TB patients with or without HIV and healthy contacts in Tanzania |
Q120718499 | Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study |
Q101560359 | Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis |
Q35507702 | Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime |
Q120251432 | Invasive procedures and risk of brain abscess: a nationwide, population-based case-control study |
Q92440079 | Long-Term Outcomes of Partial Oral Treatment of Endocarditis |
Q98195788 | Normocellular Community-Acquired Bacterial Meningitis in Adults: A Nationwide Population-Based Case Series |
Q37305589 | Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii |
Q63762072 | Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis |
Q80497353 | Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004 |
Q36189505 | Pneumocystis jiroveci. Applied molecular microbiology, epidemiology and diagnosis |
Q38953280 | Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response |
Q54534916 | Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. |
Q34495387 | Pyogenic brain abscess, a 15 year survey |
Q91563633 | Risk factors and prognosis of seizures in adults with community-acquired bacterial meningitis in Denmark: observational cohort studies |
Q44572731 | S-adenosylmethionine in plasma to test for Pneumocystis carinii pneumonia |
Q37116747 | Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review |
Q86680029 | Severely elevated C-reactive protein accompanied by prolonged high fever and leukocytosis in a healthy peripheral blood stem cell donor: an atypical granulocyte-colony-stimulating factor reaction? |
Q40445819 | Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study |
Q34502836 | Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia |
Q89901284 | Varicella Zoster Virus encephalitis in Denmark from 2015 to 2019- A nationwide prospective cohort study |
Q54977883 | [Periodic fever syndromes]. |
Q91618856 | [Voriconazole-induced periostitis] |
Search more.